ID

34473

Descrição

Prostate Cancer Localization With a Multiparametric Magnetic Resonance (MR) Approach; ODM derived from: https://clinicaltrials.gov/show/NCT01138527

Link

https://clinicaltrials.gov/show/NCT01138527

Palavras-chave

  1. 17/01/2019 17/01/2019 -
  2. 27/05/2019 27/05/2019 -
Titular dos direitos

see on clinicaltrials.gov

Transferido a

17 de janeiro de 2019

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Eligibility Prostate Cancer NCT01138527

Eligibility Prostate Cancer NCT01138527

Inclusion Criteria
Descrição

Inclusion Criteria

Alias
UMLS CUI
C1512693
biopsy-proven diagnosis of adenocarcinoma of the prostate
Descrição

ID.1

Tipo de dados

boolean

subject will sign a consent form prior to study entry
Descrição

ID.2

Tipo de dados

boolean

radical prostatectomy and histopathological exam planned
Descrição

ID.3

Tipo de dados

boolean

the time interval between last biopsy and the mr exam must be at least 4 weeks
Descrição

ID.4

Tipo de dados

boolean

the time interval between mr exam and radical prostatectomy should not exceed 12 weeks
Descrição

ID.5

Tipo de dados

boolean

Exclusion Criteria
Descrição

Exclusion Criteria

Alias
UMLS CUI
C0680251
subjects who are unable to give valid informed consent
Descrição

ID.6

Tipo de dados

boolean

subjects who are unwilling or unable to undergo an mr exam, including subjects with contra-indications to mr exams
Descrição

ID.7

Tipo de dados

boolean

therapy or surgical procedure applied to the prostate or to other organs in vicinity to the prostate: among the therapies preventing inclusion are any form of radiation therapy, cryo-therapy, thermal-therapy, therapy based on any other medication (including hormonal therapy).
Descrição

ID.8

Tipo de dados

boolean

patients under hormone deprivation therapy.
Descrição

ID.9

Tipo de dados

boolean

Similar models

Eligibility Prostate Cancer NCT01138527

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
biopsy-proven diagnosis of adenocarcinoma of the prostate
boolean
ID.2
Item
subject will sign a consent form prior to study entry
boolean
ID.3
Item
radical prostatectomy and histopathological exam planned
boolean
ID.4
Item
the time interval between last biopsy and the mr exam must be at least 4 weeks
boolean
ID.5
Item
the time interval between mr exam and radical prostatectomy should not exceed 12 weeks
boolean
Item Group
C0680251 (UMLS CUI)
ID.6
Item
subjects who are unable to give valid informed consent
boolean
ID.7
Item
subjects who are unwilling or unable to undergo an mr exam, including subjects with contra-indications to mr exams
boolean
ID.8
Item
therapy or surgical procedure applied to the prostate or to other organs in vicinity to the prostate: among the therapies preventing inclusion are any form of radiation therapy, cryo-therapy, thermal-therapy, therapy based on any other medication (including hormonal therapy).
boolean
ID.9
Item
patients under hormone deprivation therapy.
boolean

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial